Literature DB >> 25541468

Aldose reductase expression as a risk factor for cataract.

Anson Snow1, Biehuoy Shieh1, Kun-Che Chang1, Arttatrana Pal1, Patricia Lenhart1, David Ammar1, Philip Ruzycki2, Suryanarayana Palla3, G Bhanuprakesh Reddy3, J Mark Petrash4.   

Abstract

Aldose reductase (AR) is thought to play a role in the pathogenesis of diabetic eye diseases, including cataract and retinopathy. However, not all diabetics develop ocular complications. Paradoxically, some diabetics with poor metabolic control appear to be protected against retinopathy, while others with a history of excellent metabolic control develop severe complications. These observations indicate that one or more risk factors may influence the likelihood that an individual with diabetes will develop cataracts and/or retinopathy. We hypothesize that an elevated level of AR gene expression could confer higher risk for development of diabetic eye disease. To investigate this hypothesis, we examined the onset and severity of diabetes-induced cataract in transgenic mice, designated AR-TG, that were either heterozygous or homozygous for the human AR (AKR1B1) transgene construct. AR-TG mice homozygous for the transgene demonstrated a conditional cataract phenotype, whereby they developed lens vacuoles and cataract-associated structural changes only after induction of experimental diabetes; no such changes were observed in AR-TG heterozygotes or nontransgenic mice with or without experimental diabetes induction. We observed that nondiabetic AR-TG mice did not show lens structural changes even though they had lenticular sorbitol levels almost as high as the diabetic AR-TG lenses that showed early signs of cataract. Over-expression of AR led to increases in the ratio of activated to total levels of extracellular signal-regulated kinase (ERK1/2) and c-Jun N-terminal (JNK1/2), which are known to be involved in cell growth and apoptosis, respectively. After diabetes induction, AR-TG but not WT controls had decreased levels of phosphorylated as well as total ERK1/2 and JNK1/2 compared to their nondiabetic counterparts. These results indicate that high AR expression in the context of hyperglycemia and insulin deficiency may constitute a risk factor that could predispose the lens to disturbances in signaling through the ERK and JNK pathways and thereby alter the balance of cell growth and apoptosis that is critical to lens transparency and homeostasis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AKR1B1; Aldose reductase; Cataract; Diabetes

Mesh:

Substances:

Year:  2014        PMID: 25541468      PMCID: PMC4414723          DOI: 10.1016/j.cbi.2014.12.017

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  51 in total

Review 1.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.

Authors:  H M Cheng; R G González
Journal:  Metabolism       Date:  1986-04       Impact factor: 8.694

3.  Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.

Authors:  T Nakano; J M Petrash
Journal:  Biochemistry       Date:  1996-08-27       Impact factor: 3.162

Review 4.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

Review 5.  Aldose reductase: a novel therapeutic target for inflammatory pathologies.

Authors:  Kota V Ramana; Satish K Srivastava
Journal:  Int J Biochem Cell Biol       Date:  2009-09-22       Impact factor: 5.085

6.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

Review 7.  Contribution of polyol pathway to diabetes-induced oxidative stress.

Authors:  Stephen S M Chung; Eric C M Ho; Karen S L Lam; Sookja K Chung
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

8.  Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.

Authors:  Chieh Allen Lee; Guangyuan Li; Mansi D Patel; J Mark Petrash; Beth Ann Benetz; Alex Veenstra; Jaume Amengual; Johannes von Lintig; Christopher J Burant; Johnny Tang; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

9.  Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.

Authors:  Linfeng Li; Kun-Che Chang; Yaming Zhou; Biehuoy Shieh; Jessica Ponder; Adedoyin D Abraham; Hadi Ali; Anson Snow; J Mark Petrash; Daniel V LaBarbera
Journal:  J Med Chem       Date:  2013-12-23       Impact factor: 7.446

10.  Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome.

Authors:  Miguel A Lanaspa; Takuji Ishimoto; Nanxing Li; Christina Cicerchi; David J Orlicky; Philip Ruzycki; Philip Ruzicky; Christopher Rivard; Shinichiro Inaba; Carlos A Roncal-Jimenez; Elise S Bales; Christine P Diggle; Aruna Asipu; J Mark Petrash; Tomoki Kosugi; Shoichi Maruyama; Laura G Sanchez-Lozada; James L McManaman; David T Bonthron; Yuri Y Sautin; Richard J Johnson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  23 in total

1.  Aldose reductase inhibition enhances lens regeneration in mice.

Authors:  Leonid M Zukin; Michelle G Pedler; Kevin Chyung; Sarah Seiwald; Patricia Lenhart; Biehuoy Shieh; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2019-04-23       Impact factor: 5.192

2.  Influence of aldose reductase on epithelial-to-mesenchymal transition signaling in lens epithelial cells.

Authors:  Kun-Che Chang; Biehuoy Shieh; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2017-01-27       Impact factor: 5.192

3.  Aldose Reductase Mediates Transforming Growth Factor β2 (TGF-β2)-Induced Migration and Epithelial-To-Mesenchymal Transition of Lens-Derived Epithelial Cells.

Authors:  Kun-Che Chang; J Mark Petrash
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

4.  Dietary flavonoids inhibit the glycation of lens proteins: implications in the management of diabetic cataract.

Authors:  Rohan J Meshram; Kapil K Patil; Sagar H Barage; Rajesh N Gacche
Journal:  3 Biotech       Date:  2019-01-23       Impact factor: 2.406

5.  TFEB-Mediated Lysosomal Restoration Alleviates High Glucose-Induced Cataracts Via Attenuating Oxidative Stress.

Authors:  Yan Sun; Xiaoran Wang; Baoxin Chen; Mi Huang; Pengjuan Ma; Lang Xiong; Jingqi Huang; Jieping Chen; Shan Huang; Yizhi Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

6.  Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.

Authors:  Kun-Che Chang; Linfeng Li; Theresa M Sanborn; Biehuoy Shieh; Patricia Lenhart; David Ammar; Daniel V LaBarbera; J Mark Petrash
Journal:  J Nat Prod       Date:  2016-05-03       Impact factor: 4.050

7.  Role of aldose reductase in diabetes-induced retinal microglia activation.

Authors:  Kun-Che Chang; Biehuoy Shieh; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2019-01-23       Impact factor: 5.192

8.  Aldose reductase mediates retinal microglia activation.

Authors:  Kun-Che Chang; Biehuoy Shieh; J Mark Petrash
Journal:  Biochem Biophys Res Commun       Date:  2016-03-28       Impact factor: 3.575

9.  β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway.

Authors:  Ming-Bing Xiao; Dan-Dan Jin; Yu-Jie Jiao; Wen-Kai Ni; Jin-Xia Liu; Li-Shuai Qu; Cui-Hua Lu; Run-Zhou Ni; Feng Jiang; Wei-Chang Chen
Journal:  Mol Biol Rep       Date:  2018-10-10       Impact factor: 2.316

Review 10.  Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.

Authors:  Sapna Thakur; Sonu Kumar Gupta; Villayat Ali; Priyanka Singh; Malkhey Verma
Journal:  Arch Pharm Res       Date:  2021-07-19       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.